Approvals/CIMA-AEMPS/SERETIDE ACCUHALER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION

Approved

STANDARD

SERETIDE ACCUHALER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a9e8e269bb5135cb
Drug Cima Aemps Name: SERETIDE ACCUHALER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION
Register Number: 1410200C
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2025-10-29
Dosage Form: POLVO PARA INHALACIÓN
Dose: 50/250 mcg
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 29, 2025

Approval ID

a9e8e269bb5135cb

Type

Standard